EBR Systems (EBRCZ) Cash from Financing Activities (2023 - 2026)
EBR Systems (EBRCZ) posted Cash from Financing Activities of $132000.0 for Q1 2026, up 130.32% sequentially from $57311.0 in Q4 2025, and down 45.45% YoY from $242000.0 in Q1 2025.
EBR Systems (EBRCZ) Cash from Financing Activities (2023 - 2026) Analysis & Trends
EBR Systems has reported Cash from Financing Activities for 4 years, with the latest figure at $132000.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 45.45% year-over-year to $132000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.7 million (up 43.6% YoY) and the FY2025 annual result came in at $46.8 million, up 44.16% from the prior year.
- Cash from Financing Activities rose to $132000.0 in Q1 2026 per EBRCZ's latest filing, from $57311.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $46.7 million in Q2 2025 and troughed at -$138022.0 in Q3 2025.
- A 4-year average of $7.9 million and a median of $162383.0 in 2024 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 2017526.93% in 2025, down 100.47% in 2025.
- Over 4 years, Cash from Financing Activities stood at -$7569.0 in 2023, then soared by 35533.0% to $2.7 million in 2024, then plunged by 97.86% to $57311.0 in 2025, then surged by 130.32% to $132000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $132000.0, $57311.0, and -$138022.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | EBR Systems | 10.34 Mn | 10.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132,000.00 |
| Mar 31, 2026 | 132,000.00 |
| Dec 31, 2025 | 57,311.00 |
| Dec 31, 2025 | 57,311.00 |
| Sep 30, 2025 | -138,022.00 |
| Sep 30, 2025 | -138,022.00 |
| Jun 30, 2025 | 46.67 Mn |
| Jun 30, 2025 | 46.67 Mn |
| Mar 31, 2025 | 242,000.00 |
| Mar 31, 2025 | 242,000.00 |
| Dec 31, 2024 | 2.68 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Sep 30, 2024 | 29.61 Mn |
| Sep 30, 2024 | 29.61 Mn |
| Jun 30, 2024 | 2,313.00 |
| Jun 30, 2024 | 2,313.00 |
| Mar 31, 2024 | 192,766.00 |
| Mar 31, 2024 | 192,766.00 |
| Dec 31, 2023 | -7,569.00 |
| Dec 31, 2023 | -7,569.00 |